Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Raben

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
Cancer Research|March 22, 2019
Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck CancersShilpa Bhatia, Ayman Oweida, Shelby Lennon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2026
Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib TrialGlenn J Hanna, Dan P Zandberg, Deborah J Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2018
Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell InfiltrationAyman Oweida, Mohammad K Hararah, Andy Phan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 9, 2011
Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: a phase II, randomized, double-blind, placebo-controlled studyVincent Gregoire, Marc Hamoir, Changhu Chen, et al.
Journal of Neuro-Oncology|June 18, 2018
Immune checkpoint inhibitors and radiosurgery for newly diagnosed melanoma brain metastasesTyler P Robin, Robert E Breeze, Derek E Smith, et al.
The New England Journal of Medicine|February 10, 2006
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neckJames A Bonner, Paul M Harari, Jordi Giralt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck CancerSana D Karam, Krishna Reddy, Patrick J Blatchford, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
Therapeutic Intervention Using a Smad7-Based Tat Protein to Treat Radiation-Induced Oral MucositisMary-Keara Boss, Yao Ke, Li Bian, et al.
Nature Medicine|July 5, 2011
Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapyQian Huang, Fang Li, Xinjian Liu, et al.
Cancer Research|January 9, 2020
Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous CarcinomaStephen B Keysar, Nathan Gomes, Bettina Miller, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Cancer Research|March 22, 2019
Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck CancersShilpa Bhatia, Ayman Oweida, Shelby Lennon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2026
Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib TrialGlenn J Hanna, Dan P Zandberg, Deborah J Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2018
Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell InfiltrationAyman Oweida, Mohammad K Hararah, Andy Phan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 9, 2011
Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: a phase II, randomized, double-blind, placebo-controlled studyVincent Gregoire, Marc Hamoir, Changhu Chen, et al.
Journal of Neuro-Oncology|June 18, 2018
Immune checkpoint inhibitors and radiosurgery for newly diagnosed melanoma brain metastasesTyler P Robin, Robert E Breeze, Derek E Smith, et al.
The New England Journal of Medicine|February 10, 2006
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neckJames A Bonner, Paul M Harari, Jordi Giralt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck CancerSana D Karam, Krishna Reddy, Patrick J Blatchford, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
Therapeutic Intervention Using a Smad7-Based Tat Protein to Treat Radiation-Induced Oral MucositisMary-Keara Boss, Yao Ke, Li Bian, et al.
Nature Medicine|July 5, 2011
Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapyQian Huang, Fang Li, Xinjian Liu, et al.
Cancer Research|January 9, 2020
Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous CarcinomaStephen B Keysar, Nathan Gomes, Bettina Miller, et al.
Pageof 17